Paper37081086
The therapeutic potential of neurofibromin signaling pathways and binding partners.
Báez-Flores J and 2 others. Commun Biol, 2023. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. The therapeutic potential of neurofibromin signaling pathways and binding partners. Papers, record 37081086. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37081086
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neurofibromin 1 | Major topic |
| Signal Transduction | Major topic |
| Proteins | |
| Humans |
Source PubMed
References196
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19479903 | Neurofibromin physically interacts with the N-terminal domain of focal adhesion kinase. | Mol Carcinog | 2009 | https://conductscience.org/library/papers/19479903 | PubMed |
| 2 | 8332934 | Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules. | Somat Cell Mol Genet | 1993 | https://conductscience.org/library/papers/8332934 | PubMed |
| 3 | 31600280 | NF1-cAMP signaling dissociates cell type-specific contributions of striatal medium spiny neurons to reward valuation and motor control. | PLoS Biol | 2019 | https://conductscience.org/library/papers/31600280 | PubMed |
| 4 | 25342631 | Revisiting STAT3 signalling in cancer: new and unexpected biological functions. | Nat Rev Cancer | 2014 | https://conductscience.org/library/papers/25342631 | PubMed |
| 5 | 20431046 | Ras and Rap signaling in synaptic plasticity and mental disorders. | Neuroscientist | 2011 | https://conductscience.org/library/papers/20431046 | PubMed |
| 6 | 35626682 | The RAL Enigma: Distinct Roles of RALA and RALB in Cancer. | Cells | 2022 | https://conductscience.org/library/papers/35626682 | PubMed |
| 7 | 10851089 | Yeast homolog of human SAG/ROC2/Rbx2/Hrt2 is essential for cell growth, but not for germination: chip profiling implicates its role in cell cycle regulation. | Oncogene | 2000 | https://conductscience.org/library/papers/10851089 | PubMed |
| 8 | 30205045 | The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers. | Cancer Cell | 2018 | https://conductscience.org/library/papers/30205045 | PubMed |
| 9 | 16513807 | Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras. | Hum Mol Genet | 2006 | https://conductscience.org/library/papers/16513807 | PubMed |
| 10 | 25393061 | Recent developments in neurofibromatoses and RASopathies: management, diagnosis and current and future therapeutic avenues. | Am J Med Genet A | 2015 | https://conductscience.org/library/papers/25393061 | PubMed |
| 11 | 31151904 | Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. | Lancet Oncol | 2019 | https://conductscience.org/library/papers/31151904 | PubMed |
| 12 | 29438698 | Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. | Cancer Cell | 2018 | https://conductscience.org/library/papers/29438698 | PubMed |
| 13 | 16510576 | Large-scale molecular comparison of human schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues. | Cancer Res | 2006 | https://conductscience.org/library/papers/16510576 | PubMed |
| 14 | 20166958 | 5-HT6 receptor antagonists as potential therapeutics for cognitive impairment. | Curr Top Med Chem | 2010 | https://conductscience.org/library/papers/20166958 | PubMed |
| 15 | 23752589 | Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation. | Genes Dev | 2013 | https://conductscience.org/library/papers/23752589 | PubMed |
| 16 | 27791021 | Physical interaction between neurofibromin and serotonin 5-HT6 receptor promotes receptor constitutive activity. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/27791021 | PubMed |
| 17 | 1923522 | Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation. | Oncogene | 1991 | https://conductscience.org/library/papers/1923522 | PubMed |
| 18 | 11080503 | Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11080503 | PubMed |
| 19 | 9660869 | Direct interaction of CASK/LIN-2 and syndecan heparan sulfate proteoglycan and their overlapping distribution in neuronal synapses. | J Cell Biol | 1998 | https://conductscience.org/library/papers/9660869 | PubMed |
| 20 | 31933988 | Neurofibromin 1 expression is negatively correlated with malignancy and prognosis of epithelial ovarian cancer. | Int J Clin Exp Pathol | 2019 | https://conductscience.org/library/papers/31933988 | PubMed |
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42608490 | Comprehensive mapping of Neurofibromin (NF1) expression in developing mouse brain. | Brain Struct Funct | 2026 | https://conductscience.org/library/papers/42608490 | PubMed |
| 42519282 | Assessing Pain Linked to High Metabolic and Glycolytic Shift in Neurofibromatosis Type 1 (NF1) Patients by Using a Bioenergetic Biomarker: A Pilot Study. | Cureus | 2026 | https://conductscience.org/library/papers/42519282 | PubMed |
| 42510878 | Prime Editing-Based Functional Characterization Supports a Likely Pathogenic Interpretation of NF1 c.6394T>C (p.Ser2132Pro). | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42510878 | PubMed |
| 42464674 | Neurofibromin in bone disease: Mechanisms and therapeutic implications (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42464674 | PubMed |
| 42453302 | A case of neurofibromatosis type 1 with malignant peripheral nerve sheath tumor and metastatic pheochromocytoma. | JCEM Case Rep | 2026 | https://conductscience.org/library/papers/42453302 | PubMed |
| 42450067 | The Mutational Landscape of Acute Myeloid Leukemia and Its Impact. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450067 | PubMed |
| 42288551 | Genome near-haploidization in CDC73-wildtype parathyroid tumors. | Sci Rep | 2026 | https://conductscience.org/library/papers/42288551 | PubMed |
| 42051311 | Comprehensive mapping of Neurofibromin (NF1) expression in developing mouse brain. | bioRxiv | 2026 | https://conductscience.org/library/papers/42051311 | PubMed |
| 42032418 | Artificial intelligence in neurofibromatosis type I: diagnostic and therapeutic opportunities. | J Appl Genet | 2026 | https://conductscience.org/library/papers/42032418 | PubMed |
| 42020763 | Nucleus accumbens neuron subtype translatome signatures in socially stressed females. | Neuropsychopharmacology | 2026 | https://conductscience.org/library/papers/42020763 | PubMed |
| 41987183 | Genetic and non-genetic factors influencing phenotypic variability in neurofibromatosis type 1. | Orphanet J Rare Dis | 2026 | https://conductscience.org/library/papers/41987183 | PubMed |
| 41897566 | Functional Germline DNA Repair Mutations as Predictors of Acute Radiodermatitis in Breast Cancer. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/41897566 | PubMed |
| 41860014 | Apolipoprotein E Deficiency Impairs Human Microglial Proliferation Accompanied by Elevated Cellular Oxidative Stress. | J Cell Mol Med | 2026 | https://conductscience.org/library/papers/41860014 | PubMed |
| 41564118 | Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. | PLoS One | 2026 | https://conductscience.org/library/papers/41564118 | PubMed |
| 41515658 | NF1 with Multiple Cardiac Structural Abnormalities Leading to Cerebral Infarction. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/41515658 | PubMed |
| 41374990 | Neurofibromatosis Type 1: Genetic Mechanisms and Advances in Therapeutic Innovation. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41374990 | PubMed |
| 41256734 | Ataluren-Induced Functional Restoration of Neurofibromin in Fibroblasts From Neurofibromatosis Type 1 Patients With Nonsense Mutations. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/41256734 | PubMed |
| 41218342 | Subtype distribution, clinical presentation, and molecular spectrum of neurofibromatosis type 1-associated breast cancer. | Breast | 2025 | https://conductscience.org/library/papers/41218342 | PubMed |
| 41155378 | Neurofibromin Encoded by the Neurofibromatosis Type 1 (NF1) Gene Promotes the Membrane Translocation of SPRED2, Thereby Inhibiting the ERK Pathway in Breast Cancer Cells. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41155378 | PubMed |
| 41024279 | Current states in understanding oligodendroglia-mediated neurological issues in neurofibromatosis type 1 (NF1). | Acta Neuropathol Commun | 2025 | https://conductscience.org/library/papers/41024279 | PubMed |
Genes89
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37081086
GET https://conductscience.org/api/papers/v1/37081086/references?page=2